World Orphan Drug Congress 2024

The World Orphan Drug Congress is the largest, most established European meeting dedicated to orphan drugs. From cell & gene therapy, genetic testing, market access to real world evidence, this one meeting covers the whole orphan drugs value chain where science, government and manufacturers all come together to create groundbreaking progress.

Join Caidya at the upcoming WODC on October 22-25! Vice President, Rare Disease and Pediatrics, Jonathan Kornstein will be presenting a special session titled “What are the impacts of rare designation?”

Day 2 – Thursday 24 October @ 11:10
Panel: What are the impacts of rare designation?
Moderator: Daniel O’Connor, Director, Regulatory Policy & Early Access, ABPI

Speakers:

• Jonathan Kornstein, Vice President, Rare Disease and Pediatrics, Caidya
• Frauke Naumann-Winter, Head of Unit, BfArM
• Durhane Wong-Rieger, President, Chief Executive Officer, Canadian Organisation for Rare Disorder & Rare Diseases International

Meet with Us